Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Dietlein

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Academic Radiology|December 28, 2023
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor VolumeHenry Knaup, Jasmin Weindler, Lutz van Heek, et al.
EJNMMI Physics|December 13, 2018
Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseasesJochen Hammes, Lutz van Heek, Melanie Hohberg, et al.
International Journal of Molecular Sciences|October 16, 2024
Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID MiceThomas Fischer, Christopher Dietrich, Felix Dietlein, et al.
Annals of Surgery|December 3, 2009
[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancerDaniel Vallböhmer, Arnulf H Hölscher, Markus Dietlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2008
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapyMatthias Schmidt, Elfriede Bollschweiler, Markus Dietlein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Discovery of <sup>18</sup>F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive LesionsBoris D Zlatopolskiy, Heike Endepols, Philipp Krapf, et al.
NPJ Digital Medicine|January 8, 2026
Psychometric properties and detectability of GPT-4o-generated multiple-choice questions compared with human-authored items across imaging specialtiesPhilipp Linde, Florian Fichter, Markus Dietlein, et al.
European Journal of Endocrinology|July 28, 2010
Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trialJan Alexander Krämer, Kurt Werner Schmid, Henning Dralle, et al.
Leukemia & Lymphoma|June 29, 2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphomaDeniz Kahraman, Sebastian Theurich, Achim Rothe, et al.
Biomedicines|April 29, 2025
Radioiodine Exhalation Following Oral I-131 Administration in a Mouse ModelKlaus Schomäcker, Thomas Fischer, Ferdinand Sudbrock, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Academic Radiology|December 28, 2023
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor VolumeHenry Knaup, Jasmin Weindler, Lutz van Heek, et al.
EJNMMI Physics|December 13, 2018
Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseasesJochen Hammes, Lutz van Heek, Melanie Hohberg, et al.
International Journal of Molecular Sciences|October 16, 2024
Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID MiceThomas Fischer, Christopher Dietrich, Felix Dietlein, et al.
Annals of Surgery|December 3, 2009
[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancerDaniel Vallböhmer, Arnulf H Hölscher, Markus Dietlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2008
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapyMatthias Schmidt, Elfriede Bollschweiler, Markus Dietlein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Discovery of <sup>18</sup>F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive LesionsBoris D Zlatopolskiy, Heike Endepols, Philipp Krapf, et al.
NPJ Digital Medicine|January 8, 2026
Psychometric properties and detectability of GPT-4o-generated multiple-choice questions compared with human-authored items across imaging specialtiesPhilipp Linde, Florian Fichter, Markus Dietlein, et al.
European Journal of Endocrinology|July 28, 2010
Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trialJan Alexander Krämer, Kurt Werner Schmid, Henning Dralle, et al.
Leukemia & Lymphoma|June 29, 2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphomaDeniz Kahraman, Sebastian Theurich, Achim Rothe, et al.
Biomedicines|April 29, 2025
Radioiodine Exhalation Following Oral I-131 Administration in a Mouse ModelKlaus Schomäcker, Thomas Fischer, Ferdinand Sudbrock, et al.
Pageof 15